Pfizer’s Equine Portfolio Expands via Wyeth Acquisition
A new Pfizer Animal Health was unveiled last week as Pfizer’s acquisition of Wyeth, including its subsidiary Fort Dodge Animal Health, was completed.
The acquisition of many of Fort Dodge’s U.S. products allows Pfizer Animal Health to greatly diversify its U.S. portfolio, as well as broaden its offering in all animal health segments. Pfizer Animal Health now offers an enhanced portfolio